首控集團(01269.HK)重組可換股債券
首控集團(01269.HK)公佈,於2022年1月13日,該公司、Champion Sense及Principal Global訂立框架協議,以載列有關重組原可換股債券的條款及條件,包括將原可換股債券的到期日由原到期日變更爲經修訂到期日,及將原可換股債券的轉換價由原轉換價變更爲經修訂轉換價。
公告稱,Champion Sense爲原可換股債券的唯一持有人;原可換股債券的未償還本金額爲7.7億元;原可換股債券的應計利息及應付違約利息合共近2.43億元。
公告又指出,作爲原可換股債券重組安排的一部分,已於去年12月1日訂立額外抵押文件,並已於2022年1月13日訂立可換股債券購買協議以及修訂及重列協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.